Citadel Advisors’s QuidelOrtho QDEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $536K | Sell |
32,600
-6,000
| -16% | -$147K | ﹤0.01% | 9134 |
|
|
2025
Q4 | $1.1M | Buy |
38,600
+10,700
| +38% | +$290K | ﹤0.01% | 7174 |
|
|
2025
Q3 | $822K | Sell |
27,900
-294,400
| -91% | -$8.05M | ﹤0.01% | 7970 |
|
|
2025
Q2 | $9.29M | Buy |
322,300
+121,100
| +60% | +$3.58M | ﹤0.01% | 3134 |
|
|
2025
Q1 | $7.04M | Buy |
201,200
+187,400
| +1,358% | +$7.64M | ﹤0.01% | 3361 |
|
|
2024
Q4 | $615K | Sell |
13,800
-5,900
| -30% | -$241K | ﹤0.01% | 8094 |
|
|
2024
Q3 | $898K | Sell |
19,700
-8,600
| -30% | -$348K | ﹤0.01% | 7088 |
|
|
2024
Q2 | $940K | Buy |
28,300
+500
| +2% | +$20.5K | ﹤0.01% | 6710 |
|
|
2024
Q1 | $1.33M | Sell |
27,800
-12,300
| -31% | -$717K | ﹤0.01% | 6340 |
|
|
2023
Q4 | $2.96M | Sell |
40,100
-18,600
| -32% | -$1.26M | ﹤0.01% | 4670 |
|
|
2023
Q3 | $4.29M | Buy |
58,700
+32,800
| +127% | +$2.62M | ﹤0.01% | 3908 |
|
|
2023
Q2 | $2.15M | Buy |
25,900
+11,700
| +82% | +$1.02M | ﹤0.01% | 5031 |
|
|
2023
Q1 | $1.27M | Sell |
14,200
-53,300
| -79% | -$4.64M | ﹤0.01% | 6286 |
|
|
2022
Q4 | $5.78M | Sell |
67,500
-16,810
| -20% | -$1.42M | ﹤0.01% | 3615 |
|
|
2022
Q3 | $6.03M | Buy |
84,310
+15,090
| +22% | +$1.35M | ﹤0.01% | 3557 |
|
|
2022
Q2 | $6.73M | Sell |
69,220
-58,980
| -46% | -$6.01M | ﹤0.01% | 3273 |
|
|
2022
Q1 | $14.4M | Sell |
128,200
-137,900
| -52% | -$14.7M | ﹤0.01% | 2418 |
|
|
2021
Q4 | $35.9M | Buy |
266,100
+59,900
| +29% | +$8.34M | 0.01% | 1448 |
|
|
2021
Q3 | $29.1M | Sell |
206,200
-12,200
| -6% | -$1.64M | 0.01% | 1596 |
|
|
2021
Q2 | $28M | Buy |
218,400
+67,200
| +44% | +$7.91M | 0.01% | 1692 |
|
|
2021
Q1 | $19.3M | Buy |
151,200
+74,500
| +97% | +$13.8M | ﹤0.01% | 2006 |
|
|
2020
Q4 | $13.8M | Sell |
76,700
-14,800
| -16% | -$3.29M | ﹤0.01% | 2233 |
|
|
2020
Q3 | $20.1M | Buy |
91,500
+31,900
| +54% | +$7.12M | 0.01% | 1563 |
|
|
2020
Q2 | $13.3M | Buy |
59,600
+42,000
| +239% | +$6.58M | ﹤0.01% | 1895 |
|
|
2020
Q1 | $1.72M | Buy |
17,600
+12,300
| +232% | +$995K | ﹤0.01% | 4392 |
|
|
2019
Q4 | $398K | Sell |
5,300
-3,400
| -39% | -$220K | ﹤0.01% | 7164 |
|
|
2019
Q3 | $534K | Sell |
8,700
-1,300
| -13% | -$78.2K | ﹤0.01% | 6626 |
|
|
2019
Q2 | $593K | Buy |
10,000
+100
| +1% | +$6K | ﹤0.01% | 6568 |
|
|
2019
Q1 | $648K | Buy |
9,900
+4,500
| +83% | +$272K | ﹤0.01% | 6353 |
|
|
2018
Q4 | $264K | Sell |
5,400
-16,000
| -75% | -$955K | ﹤0.01% | 7478 |
|
|
2018
Q3 | $1.4M | Buy |
21,400
+4,100
| +24% | +$287K | ﹤0.01% | 4979 |
|
|
2018
Q2 | $1.15M | Buy |
17,300
+7,100
| +70% | +$429K | ﹤0.01% | 4976 |
|
|
2018
Q1 | $528K | Sell |
10,200
-1,100
| -10% | -$51.2K | ﹤0.01% | 5790 |
|
|
2017
Q4 | $490K | Sell |
11,300
-2,500
| -18% | -$102K | ﹤0.01% | 5681 |
|
|
2017
Q3 | $605K | Buy |
+13,800
| New | +$480K | ﹤0.01% | 5037 |
|
|
2016
Q1 | – | Sell |
-4,300
| Closed | -$91K | – | 7732 |
|
|
2015
Q4 | $91K | Buy |
4,300
+800
| +23% | +$16.2K | ﹤0.01% | 6799 |
|
|
2015
Q3 | $66K | Sell |
3,500
-2,200
| -39% | -$47.1K | ﹤0.01% | 7356 |
|
|
2015
Q2 | $131K | Buy |
5,700
+2,500
| +78% | +$58.2K | ﹤0.01% | 6805 |
|
|
2015
Q1 | $86K | Sell |
3,200
-5,500
| -63% | -$140K | ﹤0.01% | 6969 |
|
|
2014
Q4 | $252K | Buy |
+8,700
| New | +$236K | ﹤0.01% | 5678 |
|
|
2014
Q3 | – | Sell |
-11,200
| Closed | -$248K | – | 8343 |
|
|
2014
Q2 | $248K | Buy |
11,200
+7,400
| +195% | +$170K | ﹤0.01% | 5308 |
|
|
2014
Q1 | $104K | Buy |
+3,800
| New | +$111K | ﹤0.01% | 6161 |
|
Other funds holding QDEL
NM
VPM
RCMNY
VCM
Citadel Advisors's QDEL Position: Q4 2025 in Review
Citadel Advisors sold out of QuidelOrtho (QDEL) in Q4 2025, closing a stake of 169,010 shares — an estimated $4.58M sold.
Citadel Advisors first reported a position in QDEL in Q1 2014 and held it in 41 quarters. The position peaked at $90.5M in Q3 2022. 244 funds tracked by Wall St. Rank hold QDEL as of Q4 2025.
- Citadel Advisors reported no remaining QuidelOrtho position as of Q4 2025 after selling out during the quarter.
- Citadel Advisors sold 169,010 QuidelOrtho shares in Q4 2025, an estimated $4.58M.
- Citadel Advisors first reported a position in QuidelOrtho in Q1 2014 and held it in 41 quarters.
- Citadel Advisors's QuidelOrtho position peaked at $90.5M in Q3 2022.
- 244 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2025.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.